Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Free Articles

These articles are provided free to all readers.  Other free articles are available in Week in Review, In My Opinion, and Education Center.  To have access to all of our articles, click here...

Gracell Bio Announces Fast, Cost-Effective CAR-T Manufacturing Technology

Week in Review: Chi-Med Plans $500 Million Hong Kong IPO

FDA Official Tells China Biopharmas to Bring PD-1/PD-L1 Inhibitors to US

Week in Review: CanSino Nears $1 Billion Valuation Following Hong Kong IPO

CanSino Biologics Climbs 58% Following $161 Million Hong Kong IPO

Upcoming event
Shanghai , China
May 8-9, 2019
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China